Annotation Detail for P2RY8
Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| hsa04080 | Neuroactive ligand-receptor interaction |
| Desease ID | Desease Name |
|---|
| 2239 | Lymphoma |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of P2RY8 mRNA | decreases expression | 20064835
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.08 | 20464547 20127859 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.92 | 6695378 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.98 | 19183758 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.98 | 20146248 17474063 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.16 | 20419170 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.10 | 16530937 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.89 | 20471113 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
2.19 | 20195826 21137059 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
1.57 | 17053015 20869020 20464547 20064080 18520028 20135361 18569708 6695378 18816296 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.62 | 16381670 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.38 | 11141357 |
| MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
marker/mechanism |
|
| 19838194 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.89 | 17292933 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.57 | 19755658 10029692 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.33 | 17053015 |
| Pathway ID |
Pathway Name |
|---|
| KEGG:04080 |
Neuroactive ligand-receptor interaction |
Pharmacogenomics Knowledge Base